Year archive

Hutchmed (China) Limited — 2025 filings

All 104 regulatory filings released by Hutchmed (China) Limited (HCM) in 2025, sourced directly from the official regulator.

104 Filings

2025 Period

2025 filings (104)

Filing	Released	Lang
6-K Regulatory Filings	2025-12-31	English
Total Voting Rights Regulatory Filings	2025-12-31	English
6-K Regulatory Filings	2025-12-30	English
China NDA Acceptance-Savolitinib in Gastric Cancer Regulatory Filings	2025-12-30	English
6-K Regulatory Filings	2025-12-29	English
NDA Acceptance in China for Fanregratinib Regulatory Filings	2025-12-29	English
Blocklisting Six Monthly Return Regulatory Filings	2025-12-29	English
6-K Regulatory Filings	2025-12-17	English
HUTCHMED Initiates Development of ATTC Candidate Regulatory Filings	2025-12-17	English
6-K Regulatory Filings	2025-12-08	English
Expanded NRDL Coverage + CIDL Inclusion in China Regulatory Filings	2025-12-08	English
6-K Regulatory Filings	2025-11-28	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-11-28	English
HUTCHMED Highlights Data at ESMO and ASH Regulatory Filings	2025-11-27	English
6-K Regulatory Filings	2025-11-05	English
Enrollment Complete in SAFFRON Global Phase III Regulatory Filings	2025-11-05	English
6-K Regulatory Filings	2025-11-03	English
Updates from R&D Event Regulatory Filings	2025-11-03	English
6-K Regulatory Filings	2025-10-23	English
HUTCHMED Presents Data at AACR NCI EORTC Regulatory Filings	2025-10-23	English
6-K Regulatory Filings	2025-10-21	English
Vesting of awards under Long Term Incentive Plan Director's Dealing	2025-10-21	English
6-K Regulatory Filings	2025-10-14	English
Appointment of Independent Non-executive Director Board/Management Information	2025-10-14	English
Data to be Presented at the 2025 ESMO Congress Earnings Release Q1 2025	2025-10-13	English
6-K Regulatory Filings	2025-10-02	English
HUTCHMED Highlights Data to be Presented at ESMO Regulatory Filings	2025-10-02	English
6-K Declaration of Voting Results & Voting Rights Announcements	2025-09-30	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-09-30	English
6-K Regulatory Filings	2025-09-12	English
HUTCHMED to Present R&D Updates on October 31 2025 Regulatory Filings	2025-09-12	English
6-K Regulatory Filings	2025-09-05	English
HUTCHMED Highlights Data to be Presented at CSCO Regulatory Filings	2025-09-05	English
Directorate Change Board/Management Information	2025-08-26	English
6-K Board/Management Information	2025-08-25	English
6-K Regulatory Filings	2025-08-20	English
HUTCHMED Completes Enrollment of Phase III Trial Regulatory Filings	2025-08-20	English
6-K Interim / Quarterly Report	2025-08-07	English
2025 Interim Results Interim / Quarterly Report H1 2025	2025-08-07	English
6-K Report Publication Announcement	2025-07-03	English
HUTCHMED to Announce 2025 Half-Year Results Report Publication Announcement	2025-07-03	English
6-K Regulatory Filings	2025-07-02	English
Update on Joint Corporate Brokers in London Regulatory Filings	2025-07-02	English
6-K Regulatory Filings	2025-06-30	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2025-06-30	English
Blocklisting Six Monthly Return Remuneration Information	2025-06-30	English
China Approval based on Phase III SACHI Trial Regulatory Filings	2025-06-30	English
6-K Regulatory Filings	2025-06-10	English
Grant of Share Options and Awards under LTIP Director's Dealing	2025-06-10	English
6-K Regulatory Filings	2025-06-05	English
HUTCHMED and Innovent Announce NDA Acceptance Regulatory Filings	2025-06-05	English
6-K Regulatory Filings	2025-06-02	English
HUTCHMED Highlights SACHI Phase III Data at ASCO Regulatory Filings	2025-06-02	English
Regulatory Filings 2025 Regulatory Filings	2025-05-30	English
6-K Regulatory Filings	2025-05-30	English
Total Voting Rights Regulatory Filings	2025-05-30	English
Regulatory Filings 2025 Regulatory Filings	2025-05-27	English
6-K Regulatory Filings	2025-05-23	English
HUTCHMED Highlights Data to be Presented at ASCO Regulatory Filings	2025-05-23	English
Regulatory Filings 2025 Regulatory Filings	2025-05-14	English
6-K Declaration of Voting Results & Voting Rights Announcements	2025-05-13	English
AGM held on May 13, 2025 – Poll Results Declaration of Voting Results & Voting Rights Announcements	2025-05-13	English
6-K Regulatory Filings	2025-04-24	English
HUTCHMED - Data to be Presented at AACR 2025 Regulatory Filings	2025-04-24	English
6-K Regulatory Filings	2025-04-22	English
HUTCHMED Completes Enrollment of Phase II Study Regulatory Filings	2025-04-22	English
FORM 6-K Report Publication Announcement	2025-04-07	English
2024 Annual Report and Notice of AGM Report Publication Announcement	2025-04-07	English
6-K Declaration of Voting Results & Voting Rights Announcements	2025-03-31	English
Extraordinary General Meeting – Poll Results Declaration of Voting Results & Voting Rights Announcements	2025-03-31	English
6-K Regulatory Filings	2025-03-21	English
NMPA Conditional Approval for TAZVERIK® Regulatory Filings	2025-03-21	English
6-K Regulatory Filings	2025-03-20	English
Retirement of Independent Non-executive Directors Board/Management Information	2025-03-20	English
HUTCHMED Highlights Savolitinib SAVANNAH Phase II Regulatory Filings	2025-03-20	English
Publication of Form 20-F Report Publication Announcement	2025-03-19	English
FORM 6-K Regulatory Filings	2025-03-19	English
20-F Annual Report FY 2024	2025-03-19	English
2024 Final Results and Business Updates Earnings Release FY 2024	2025-03-19	English
6-K Regulatory Filings	2025-03-19	English
Phase II/III Study of Fruquintinib and Sintilimab Regulatory Filings	2025-03-19	English
6-K Regulatory Filings	2025-03-14	English
Vesting of awards under Long Term Incentive Plan Director's Dealing	2025-03-14	English
Adoption of the 2025 Long Term Incentive Plan Regulatory Filings	2025-03-14	English
FORM 6-K Regulatory Filings	2025-03-13	English
Notice of Extraordinary General Meeting AGM Information	2025-03-13	English
6-K Regulatory Filings	2025-03-06	English
Completed Enrollment of Phase II Study Regulatory Filings	2025-03-06	English
6-K Board/Management Information	2025-03-05	English
Directorate Change Board/Management Information	2025-03-05	English
6-K Regulatory Filings	2025-03-03	English
Overseas Regulatory Announcement M&A Activity	2025-03-03	English
6-K Regulatory Filings	2025-02-28	English
Overseas Regulatory Announcement Regulatory Filings	2025-02-28	English
6-K Regulatory Filings	2025-02-19	English
Notice of Results Report Publication Announcement	2025-02-19	English
6-K Regulatory Filings	2025-01-28	English
Overseas Regulatory Announcement Regulatory Filings	2025-01-28	English
6-K Regulatory Filings	2025-01-14	English
Full Approval for ORPATHYS in China Regulatory Filings	2025-01-14	English
6-K Regulatory Filings	2025-01-02	English
China NDA Acceptance for ORPATHYS and TAGRISSO Regulatory Filings	2025-01-02	English
Overseas Regulatory Announcement M&A Activity	2025-01-02	English
US$608m Divestment of Non-Core Joint Venture Regulatory Filings	2025-01-02	English

Filings by year

2026 30 filings
2025 104 filings
2024 105 filings
2023 108 filings
2022 96 filings
2021 149 filings
2020 122 filings
2019 71 filings
2018 77 filings
2017 88 filings
2016 81 filings
2015 53 filings
2014 28 filings
2013 23 filings